NDLI: C-reactive protein and coronary heart disease : Diagnostic and therapeutic implications for primary prevention

Please wait, while we are loading the content...

Improved identification of acute coronary syndromes with delta cardiac serum marker measurements during the emergency department evaluation of chest pain patients

Rationale for the early clinical application of markers of ischemia in patients with suspected acute coronary syndromes

Clinical and pathobiologic considerations in the evaluation of markers of myocardial ischemia

Markers of platelet activation and thrombin generation

Analysis of the Albumin cobalt Binding (ACB$^{TM}$) test as an adjunct to cardiac troponin I for the early detection of acute myocardial infarction

C-reactive protein and coronary heart disease : Diagnostic and therapeutic implications for primary prevention

B-type natriuretic peptide levels : Diagnostic and therapeutic potential

Mammalian cardenolides as biomarkers in congestive heart failure

Determination of the falloff constant (k $_{ f }$) from modeling biochemical marker release : A new variable for discriminating therapies

Cardiovascular Toxicology : Volume 1, Issue 1, March 2001

C-reactive protein and coronary heart disease : Diagnostic and therapeutic implications for primary prevention

Content Provider	Springer Nature Link
Author	Rifai, Nader
Copyright Year	2001
Abstract	Coronary heart disease (CHD) is the leading cause of death in the industrialized world. Recent laboratory and clinical studies have shown that inflammation plays a pivotal role in the inception, progression, and destabilization of atheromas. The acute-phase reactant C-reactive protein (CRP) has been shown to reflect systemic and, perhaps, vascular inflammation and to predict future cardiovascular events in asymptomatic individuals. The relative risk associated with CRP is independent of other cardiovascular disease risk factors. High-sensitivity assays (hs-CRP) are needed for the measurement of CRP concentration for the purpose of predicting the risk of future coronary events. Available assays must be standardized because patients' results will be interpreted using population-based cutpoints. An algorithm for risk stratification incorporating hs-CRP and total cholesterol to high-density lipoprotein cholesterol ratio has been developed. Statin class drugs and aspirin appear to modulate CHD risk in those with increased hs-CRP concentration. Several prospective studies, are now underway to specifically develop novel clinical utilities and therapeutic strategies for hs-CRP.
Starting Page	153
Ending Page	157
Page Count	5
File Format	PDF
ISSN	15307905
Journal	Cardiovascular Toxicology
Volume Number	1
Issue Number	2
e-ISSN	15590259
Language	English
Publisher	Humana Press
Publisher Date	2001-01-01
Publisher Place	Totowa
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Review atherosclerosis inflammation C-reactive protein myocardial infarction Pharmacology/Toxicology Cardiology
Content Type	Text
Resource Type	Article
Subject	Molecular Biology Toxicology Cardiology and Cardiovascular Medicine

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

C-reactive protein, inflammation and coronary heart disease

Troponins in patients with acture coronary syndromes : Biologic, diagnostic, and therapeutic implications

C-reactive protein and coronary heart disease - risk marker or risk factor?

Predictive value of C-reactive protein after drug-eluting stent implantation.

Inflammation during Percutaneous Coronary Intervention—Prognostic Value, Mechanisms and Therapeutic Targets

Prognostic implications of C-reactive protein and troponin following percutaneous coronary intervention.

High sensitivity C-reactive protein (hsCRP) & cardiovascular disease: An Indian perspective

Acute Myocardial Infarction Following Oral Methyl-Ergometrine Intake

Preventing myocardial infarction: use and limitation of non-invasive imaging modalities

C-reactive protein and coronary heart disease : Diagnostic and therapeutic implications for primary prevention

Similar Documents

C-reactive protein, inflammation and coronary heart disease

Troponins in patients with acture coronary syndromes : Biologic, diagnostic, and therapeutic implications

C-reactive protein and coronary heart disease - risk marker or risk factor?

Predictive value of C-reactive protein after drug-eluting stent implantation.

Inflammation during Percutaneous Coronary Intervention—Prognostic Value, Mechanisms and Therapeutic Targets

Prognostic implications of C-reactive protein and troponin following percutaneous coronary intervention.

High sensitivity C-reactive protein (hsCRP) & cardiovascular disease: An Indian perspective

Acute Myocardial Infarction Following Oral Methyl-Ergometrine Intake

Preventing myocardial infarction: use and limitation of non-invasive imaging modalities

C-reactive protein and coronary heart disease : Diagnostic and therapeutic implications for primary prevention